BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26149053)

  • 1. Medical device-induced thrombosis: what causes it and how can we prevent it?
    Jaffer IH; Fredenburgh JC; Hirsh J; Weitz JI
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S72-81. PubMed ID: 26149053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic science review: nitric oxide--releasing prosthetic materials.
    Varu VN; Tsihlis ND; Kibbe MR
    Vasc Endovascular Surg; 2009; 43(2):121-31. PubMed ID: 18799500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis.
    Gerrah R; Sunstrom Pa-C RE; Hohimer AR
    Vascular; 2015 Oct; 23(5):513-8. PubMed ID: 25406265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem.
    Jaffer IH; Weitz JI
    Acta Biomater; 2019 Aug; 94():2-10. PubMed ID: 31226480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
    Baumann Kreuziger LM; Kim B; Wieselthaler GM
    J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug eluting grafts for hemodialysis access.
    Glickman M
    J Vasc Access; 2017 Mar; 18(Suppl. 1):53-55. PubMed ID: 28297060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombogenic modification of small-diameter microfibrous vascular grafts.
    Hashi CK; Derugin N; Janairo RR; Lee R; Schultz D; Lotz J; Li S
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1621-7. PubMed ID: 20466974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment alternatives in mechanical valve thrombosis].
    Duran NE; Biteker M; Ozkan M
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):420-5. PubMed ID: 19155650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
    Al Shakarchi J; Inston N; Jones RG; Maclaine G; Hollinworth D
    J Vasc Surg; 2016 Apr; 63(4):1026-33. PubMed ID: 26826055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological basis of thrombosis and bleeding in patients with ventricular assist devices.
    John R; Lee S
    J Cardiovasc Transl Res; 2009 Mar; 2(1):63-70. PubMed ID: 20559970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applications of heparin in vascular tissue engineering.
    Aslani S; Kabiri M; HosseinZadeh S; Hanaee-Ahvaz H; Taherzadeh ES; Soleimani M
    Microvasc Res; 2020 Sep; 131():104027. PubMed ID: 32505610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.
    Susen S; Rauch A; Van Belle E; Vincentelli A; Lenting PJ
    J Thromb Haemost; 2015 Oct; 13(10):1757-67. PubMed ID: 26302994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair.
    Mafeld S; Annamalai G; Lindsay TF; Zhong I; Tarulli E; Mironov O; Tan KT
    Vasc Endovascular Surg; 2019 Jul; 53(5):395-400. PubMed ID: 31018828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy for the CardioWest temporary total artificial heart.
    Ensor CR; Cahoon WD; Crouch MA; Katlaps GJ; Hess ML; Cooke RH; Gunnerson KJ; Kasirajan V
    Tex Heart Inst J; 2010; 37(2):149-58. PubMed ID: 20401285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Effect of Crosslinking Method of Poly(Vinyl Alcohol) Hydrogels on Thrombogenicity.
    Bates NM; Puy C; Jurney PL; McCarty OJT; Hinds MT
    Cardiovasc Eng Technol; 2020 Aug; 11(4):448-455. PubMed ID: 32607901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombosis and cancer. An update of our knowledge].
    Tumori; 2006; 92(5):23-41. PubMed ID: 17168451
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel thromboresistant materials.
    Jordan SW; Chaikof EL
    J Vasc Surg; 2007 Jun; 45 Suppl A():A104-15. PubMed ID: 17544031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular assist device thrombosis: Mind your P's &Q's-Pumps, patients, and pills.
    Massicotte P; Snyder T; Stulak J; Baumann Kreuziger L
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1503-1506. PubMed ID: 27964986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.